These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Safety and tolerability of serial home infusions of nesiritide for advanced heart failure. Chung ES; Menon SG; Daly KA; Atkinson J; Peterson T; Robertson R; Ibanez K; Kereiakes DJ Am J Cardiol; 2006 May; 97(9):1370-3. PubMed ID: 16635613 [TBL] [Abstract][Full Text] [Related]
8. [Nesiritide in heart failure: commercial success or therapeutic advance?]. Stampfli T; Perrier A Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047 [TBL] [Abstract][Full Text] [Related]
9. Nesiritide for acute decompensated heart failure. Alhosaini H Am Fam Physician; 2006 Oct; 74(8):1279; author reply 1279-80. PubMed ID: 17087421 [No Abstract] [Full Text] [Related]
10. Rituximab (Rituxan) for rheumatoid arthritis. Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143 [No Abstract] [Full Text] [Related]
11. Nesiritide: the latest drug for treating heart failure. Fontana D Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809 [No Abstract] [Full Text] [Related]
12. Nesiritide in acute decompensated heart failure: to use or not to use, that is the question? Kapoor JR Am J Cardiol; 2007 Aug; 100(4):745-6. PubMed ID: 17697845 [No Abstract] [Full Text] [Related]
13. Is nesiritide really that good or that bad? Cheng TO Am Heart J; 2006 Apr; 151(4):e1; author reply e3. PubMed ID: 16569525 [No Abstract] [Full Text] [Related]
14. Clinical improvement with repeated courses of intravenous B-type natriuretic peptide in refractory heart failure. Spevack DM; Matros T; Shah A; Dweck E; Tunick PA Eur J Heart Fail; 2004 Aug; 6(5):611-3. PubMed ID: 15302009 [No Abstract] [Full Text] [Related]
15. Is there a use for nesiritide in pediatric patients? Schamberger MS J Intensive Care Med; 2004; 19(3):171-3. PubMed ID: 15154998 [No Abstract] [Full Text] [Related]
16. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193 [TBL] [Abstract][Full Text] [Related]
17. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
18. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
19. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial). Yancy CW; Singh A Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598 [TBL] [Abstract][Full Text] [Related]